Imprida HCT European Union - English - EMA (European Medicines Agency)

imprida hct

novartis europharm ltd. - amlodipine, valsartan, hydrochlorothiazide - hypertension - angiotensin ii antagonists, plain, angiotensin ii antagonists, combinations - treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (hct), taken either as three single-component formulations or as a dual-component and a single-component formulation.

Exforge HCT Tablet 10mg160mg12.5mg Singapore - English - HSA (Health Sciences Authority)

exforge hct tablet 10mg160mg12.5mg

novartis (singapore) pte ltd - amlodipine besylate 13.87mg eqv amlodipine; hydrochlorothiazide; valsartan - tablet, film coated - 10.00mg - amlodipine besylate 13.87mg eqv amlodipine 10.00mg; hydrochlorothiazide 12.50mg; valsartan 160.00mg

Exforge HCT Tablet 10mg160mg25mg Singapore - English - HSA (Health Sciences Authority)

exforge hct tablet 10mg160mg25mg

novartis (singapore) pte ltd - amlodipine besylate 13.87mg eqv amlodipine; hydrochlorothiazide; valsartan - tablet, film coated - 10.00mg - amlodipine besylate 13.87mg eqv amlodipine 10.00mg; hydrochlorothiazide 25.00mg; valsartan 160.00mg

Exforge HCT Tablet 5mg160mg12.5mg Singapore - English - HSA (Health Sciences Authority)

exforge hct tablet 5mg160mg12.5mg

novartis (singapore) pte ltd - amlodipine besylate 6.94mg eqv amlodipine; hydrochlorothiazide; valsartan - tablet, film coated - 5mg - amlodipine besylate 6.94mg eqv amlodipine 5mg; hydrochlorothiazide 12.50mg; valsartan 160.00mg

Exforge HCT Tablet 5mg160mg25mg Singapore - English - HSA (Health Sciences Authority)

exforge hct tablet 5mg160mg25mg

novartis (singapore) pte ltd - amlodipine besylate 6.94mg eqv amlodipine; hydrochlorothiazide; valsartan - tablet, film coated - 5.00mg - amlodipine besylate 6.94mg eqv amlodipine 5.00mg; hydrochlorothiazide 25.00mg; valsartan 160.00mg